Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced a proposal to acquire all of the outstanding shares of Mylan N.V. (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE